Summary & Overview
CPT 20200: Superficial Muscle Biopsy
CPT code 20200 represents a surgical muscle biopsy to obtain superficial muscle tissue for diagnostic evaluation. The code is used when clinicians suspect neuromuscular disease, inflammatory myopathy, infection, or metabolic conditions that require histologic or microbiologic examination. Nationally, muscle biopsy remains an important diagnostic tool in neurology and pathology pathways because tissue analysis can change diagnosis and influence treatment plans.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The coverage landscape and payment practices for surgical biopsies like this one affect access to definitive diagnosis across outpatient and hospital settings.
Readers will find clinical context for the procedure, typical settings where it is performed, and the elements that influence billing and coding for a superficial muscle biopsy. The publication summarizes benchmarks and common payer practices where available, highlights policy and coding considerations that impact claim processing, and outlines what documentation commonly supports medical necessity. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 20200 describes a muscle biopsy performed to obtain a sample of superficial muscle tissue for diagnostic analysis of a suspected medical condition or infection. The procedure targets superficial muscle, defined as muscle tissue just below the skin or fascia, and yields specimens for histologic, microbiologic, or molecular testing.
Service Type: Surgical procedure — biopsy of superficial muscle
Typical Site of Service: Outpatient surgical suite, ambulatory surgery center, or hospital outpatient setting
Clinical & Coding Specifications
Clinical Context
A 45-year-old patient presents with progressive proximal muscle weakness, myalgias, and elevated creatine kinase. After initial evaluation including history, physical exam, baseline labs, and imaging (as indicated), the neuromuscular specialist recommends a diagnostic muscle biopsy to obtain superficial muscle tissue for histopathology, immunohistochemistry, and microbiology to evaluate for inflammatory myopathy, suspected muscular dystrophy, metabolic myopathy, or infectious myositis. The procedure is performed in an outpatient minor procedure room or ambulatory surgery center under local anesthesia with or without monitored anesthesia care. The surgeon marks the biopsy site over an affected superficial muscle (commonly deltoid or quadriceps), prepares sterile field, obtains a small open or punch sample of superficial muscle just below skin/fascia, achieves hemostasis, closes the incision with sutures or steri-strips, and sends specimens to pathology and microbiology. Typical workflow includes pre-procedure consent, review of anticoagulation status, local anesthesia, tissue procurement, specimen labeling and documentation, post-procedure instructions, and short follow-up visit for suture removal and pathology review.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier (default) | Use when no special circumstance modifier applies |